FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Frank Ruschitzka

Research Profile

Anatomy

Endothelium, Vascular

Disorders

Chemicals & Drugs

Procedures

Double-Blind Method

Concepts & Ideas

Co-author Network

Publications

TOP 3
Georg M Fröhlich; Philipp Keller; Thomas F Lüscher; Pascal Meier; Georg Noll; Martin Osranek; Markus Reinthaler; Frank Ruschitzka; Florian Schmid; Frank Enseleit; Christian Falk; Mathias Wolfrum; Felix C Tanner
Haemodynamically irrelevant pericardial effusion is associated with increased mortality in patients with chronic heart failure.
Georg Marcus Fröhlich; Mathias Hermann; Johannes Holzmeister; Thomas F Lüscher; Georg Noll; Kaspar Rufibach; Frank Ruschitzka; Michelle von Babo; Markus Wilhelm; Mathias Wolfrum; Reto Berli; Frank Enseleit; Michelle Frank; Volkmar Falk
Response to letters regarding article, “statins and the risk of cancer after heart transplantation”.
Thomas F Lüscher; Brahmajee Nallamothu; Frank Ruschitzka; Bernard Gersh; Gerhard Hindricks; Ulf Landmesser; William Wijns
The European Heart Journal on the move: can scientific publishing be further improved?

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Frank Ruschitzka (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Georg M Fröhlich; Philipp Keller; Thomas F Lüscher; Pascal Meier; Georg Noll; Martin Osranek; Markus Reinthaler; Frank Ruschitzka; Florian Schmid; Frank Enseleit; Christian Falk; Mathias Wolfrum; Felix C Tanner
Haemodynamically irrelevant pericardial effusion is associated with increased mortality in patients with chronic heart failure.
European heart journal 2013;34(19):1414-23.
2013: Georg Marcus Fröhlich; Mathias Hermann; Johannes Holzmeister; Thomas F Lüscher; Georg Noll; Kaspar Rufibach; Frank Ruschitzka; Michelle von Babo; Markus Wilhelm; Mathias Wolfrum; Reto Berli; Frank Enseleit; Michelle Frank; Volkmar Falk
Response to letters regarding article, “statins and the risk of cancer after heart transplantation”.
Circulation 2013;127(5):e442.
2013: Thomas F Lüscher; Brahmajee Nallamothu; Frank Ruschitzka; Bernard Gersh; Gerhard Hindricks; Ulf Landmesser; William Wijns
The European Heart Journal on the move: can scientific publishing be further improved?
European heart journal 2013;34(6):409-15.
2013: Christian Templin; Jelena R Ghadri; Thomas F Lüscher; Georg Noll; Frank Ruschitzka
Allograft vasculopathy vs. coronary artery disease: comparison by optical coherence tomography.
European heart journal 2013;34(2):137.
2012: Philipp Jakob; Nicolle Kraenkel; Heiner Adams; Christof Baltes; Christian Besler; Sylvie Briand; Carola Doerries; Thomas F Lüscher; Costantina Manes; Pavani Mocharla; Maja Mueller; Georg Noll; Markus Rudin; Frank Ruschitzka; Christian Templin; Mathias Wolfrum; Ulf Landmesser
Loss of angiomiR-126 and 130a in angiogenic early outgrowth cells from patients with chronic heart failure: role for impaired in vivo neovascularization and cardiac repair capacity.
Circulation 2012;126(25):2962-75.
2012: Thomas F Lüscher; Frank Ruschitzka; Ulf Landmesser; Diederick E Grobbee
Working together in cardiovascular prevention: the common mission of the European Heart Journal and the European Journal of Preventive Cardiology.
European journal of preventive cardiology 2012;19(6):1217-26.
2012: Stephan Winnik; Jeroen J Bax; Pierre-Alain Clavien; Kim Fox; Matthias Hasun; Michel Komajda; Thomas F Lüscher; Ciara Mundow; Dimitri A Raptis; Frank Ruschitzka; Thimotheus Speer; Michal Tendera; Frans Van de Werf; Janina H Walker; Christian M Matter
From abstract to impact in cardiovascular research: factors predicting publication and citation.
European heart journal 2012;33(24):3034-45.
2012: Thomas F Lüscher; Frank Ruschitzka; Wiek H van Gilst; Ulf Landmesser; Adriaan A Voors; Dirk J van Veldhuisen
The European Heart Journal and the European Journal of Heart Failure: partners in scientific publishing.
European journal of heart failure 2012;14(10):1075-82.
2012: Andreas J Flammer; Matthias Hermann; Astrid Hirt; Priska Kaiser; Antoine Lévêques; Thomas F Lüscher; Georg Noll; Daniel Périat; Frank Ruschitzka; Mauro Serafini; Isabella Sudano; Rajeev Thomas; Mathias Wolfrum; Frank Enseleit; Roberto Corti
Cardiovascular effects of flavanol-rich chocolate in patients with heart failure.
European heart journal 2012;33(17):2172-80.
2012: Isabella Sudano; Susanne Roas; Frank Ruschitzka; Roberto Corti; Frank Enseleit; Andreas J Flammer; Georg Noll
Cocoa, blood pressure, and vascular function.
Current hypertension reports 2012;14(4):279-84.
2012: Frank Ruschitzka; Stefano Taddei
Angiotensin-converting enzyme inhibitors: first-line agents in cardiovascular protection?
European heart journal 2012;33(16):1996-8.
2012: Isabella Sudano; Frank Enseleit; Andreas J Flammer; Georg Noll; Susanne Roas; Frank Ruschitzka
Nonsteroidal antiinflammatory drugs, acetaminophen, and hypertension.
Current hypertension reports 2012;14(4):304-9.
2012: Frank Ruschitzka
The challenge of nonresponders to cardiac resynchronization therapy: lessons learned from oncology.
Heart rhythm : the official journal of the Heart Rhythm Society 2012;9(8 Suppl):S14-7.
2012: Andreas J Flammer; Frank Ruschitzka
Psoriasis and atherosclerosis: two plaques, one syndrome?
European heart journal 2012;33(16):1989-91.
2012: Georg Marcus Fröhlich; Mathias Hermann; Johannes Holzmeister; Thomas F Lüscher; Georg Noll; Kaspar Rufibach; Reto Berli; Frank Enseleit; Volkmar Falk; Michelle Frank; Michelle von Babo; Markus Wilhelm; Mathias Wolfrum; Frank Ruschitzka
Statins and the risk of cancer after heart transplantation.
Circulation 2012;126(4):440-7.
2012: Frank Enseleit; Andreas J Flammer; Georg M Fröhlich; Sarah R Haile; Astrid Hirt; Petra Högger; Priska Kaiser; Nazmi Krasniqi; Thomas F Lüscher; Christian M Matter; Michel Neidhart; Daniel Périat; Frank Ruschitzka; Isabella Sudano; Klaus Uhlenhut; Stephan Winnik; Mathias Wolfrum; Georg Noll
Effects of Pycnogenol on endothelial function in patients with stable coronary artery disease: a double-blind, randomized, placebo-controlled, cross-over study.
European heart journal 2012;33(13):1589-97.
2012: Branko Simic; Urs Stalder; Sidney G Shaw; Christian Besler; Laurent Bigler; Carola Dörries; Matthias Hermann; Thomas F Lüscher; Frank Ruschitzka
Torcetrapib impairs endothelial function in hypertension.
European heart journal 2012;33(13):1615-24.
2012: Isabella Sudano; Andreas J Flammer; Georg Noll; S Roas; Frank Ruschitzka
[Effect of paracetamol (acetaminophen) on blood pressure in patients with coronary heart disease].
Praxis 2012;101(12):775-9.
2012: Thomas F Lüscher; Frank Ruschitzka; Bernard Gersh; Gerhard Hendricks; Ulf Landmesser; William Wijns
The best of the European Heart Journal: look back with pride.
European heart journal 2012;33(10):1161-71.
2012: Rémy Chenevard; Roberto Corti; Frank Enseleit; Andreas J Flammer; Matthias Hermann; David Hürlimann; Thomas F Lüscher; Georg Noll; Lukas E Spieker; Isabella Sudano; Markus Béchir; Frank Ruschitzka
Reconstituted HDL in acute coronary syndromes.
Cardiovascular therapeutics 2012;30(2):e51-7.
2012: Georg M Fröhlich; Philipp Keller; Thomas F Lüscher; Georg Noll; Frank Ruschitzka; Florian Schmid; Boris Schoch; Isabella Sudano; Frank Enseleit
Takotsubo cardiomyopathy has a unique cardiac biomarker profile: NT-proBNP/myoglobin and NT-proBNP/troponin T ratios for the differential diagnosis of acute coronary syndromes and stress induced cardiomyopathy.
International journal of cardiology 2012;154(3):328-32.
2011: Jan Steffel; Firat Duru; Johannes Holzmeister; AF Hürlimann; Nazmi Krasniqi; Thomas F Lüscher; Gligor Milosevic; Mehdi Namdar; Frank Ruschitzka; David Hürlimann
Characteristics and long-term outcome of echocardiographic super-responders to cardiac resynchronisation therapy: 'real world' experience from a single tertiary care centre.
Heart (British Cardiac Society) 2011;97(20):1668-74.
2011: Mihai Gheorghiade; Frank Ruschitzka
Beyond dyspnoea as an endpoint in acute heart failure trials.
European heart journal 2011;32(12):1442-5.
2011: Stefan Toggweiler; Oliver Borst; Frank Enseleit; Matthias Hermann; Frank Ruschitzka; Thomas F Lüscher; Georg Noll
NT-proBNP provides incremental prognostic information in cardiac outpatients with and without echocardiographic findings.
Clinical cardiology 2011;34(3):183-8.
2011: Frank Enseleit; Frank Ruschitzka
Is there a link between angiotensin receptor blockers and cancer?
Current hypertension reports 2011;13(1):5-7.
2011: Maximilian Y Emmert; René Prêtre; Frank Ruschitzka; F Krähenmann; Volkmar Falk; Markus J Wilhelm
Peripartum cardiomyopathy with cardiogenic shock: recovery after prolactin inhibition and mechanical support.
The Annals of thoracic surgery 2011;91(1):274-6.
2011: Frank Ruschitzka; William T Abraham
Heart failure: In search of improved therapies for acute heart failure.
Nature reviews. Cardiology 2011;8(1):9-10.
2010: Rutger J van Bommel; Hidekazu Tanaka; Victoria Delgado; Matteo Bertini; Carel Jan Willem Borleffs; Nina Ajmone Marsan; Johannes Holzmeister; Frank Ruschitzka; Martin J Schalij; Jeroen J Bax; John Gorcsan
Association of intraventricular mechanical dyssynchrony with response to cardiac resynchronization therapy in heart failure patients with a narrow QRS complex.
European heart journal 2010;31(24):3054-62.
2010: Isabella Sudano; Andreas J Flammer; Daniel Périat; Frank Enseleit; Matthias Hermann; Mathias Wolfrum; Astrid Hirt; Priska Kaiser; David Hurlimann; Michel Neidhart; Steffen GAY; Johannes Holzmeister; Juerg Nussberger; Pavani Mocharla; Ulf Landmesser; Sarah R Haile; Roberto Corti; Paul M Vanhoutte; Thomas F Lüscher; Georg Noll; Frank Ruschitzka
Acetaminophen increases blood pressure in patients with coronary artery disease.
Circulation 2010;122(18):1789-96.
2010: Thomas F Lüscher; Josep Brugada; Bernard J Gersh; Ulf Landmesser; Patrick Washington Serruys; Sabina Murphy; Susanne Dedecke; Sam Rogers; Frank Ruschitzka
Happy birthday European Heart Journal: in 30 years, from Cinderella to centre stage.
European heart journal 2010;31(16):1945-50.
2010: Frank Enseleit; Thomas F Lüscher; Frank Ruschitzka
Darusentan, a selective endothelin A receptor antagonist, for the oral treatment of resistant hypertension.
Therapeutic advances in cardiovascular disease 2010;4(4):231-40.
2010: Georg Fröhlich; Jan Steffel; David Hürlimann; Frank Enseleit; Thomas F Lüscher; Frank Ruschitzka; William T Abraham; Johannes Holzmeister
Upgrading to resynchronization therapy after chronic right ventricular pacing improves left ventricular remodelling.
European heart journal 2010;31(12):1477-85.
2010: Frank Enseleit; Stephan Michels; Frank Ruschitzka
Anti-VEGF therapies and blood pressure: more than meets the eye.
Current hypertension reports 2010;12(1):33-8.
2010: Frank Enseleit; Frank Ruschitzka
Darusentan in resistant hypertension: lost in translation.
Current hypertension reports 2010;12(1):1-3.
2009: Franz H Messerli; Sripal Bangalore; Frank Ruschitzka
Angiotensin receptor blockers: baseline therapy in hypertension?
European heart journal 2009;30(20):2427-30.
2009: Matthew C Becker; Thomas H Wang; Lisa Wisniewski; Kathy Wolski; Peter Libby; Thomas F Lüscher; Jeffrey S Borer; Alice M Mascette; M Elaine Husni; Daniel H Solomon; David Y Graham; Neville D Yeomans; Henry Krum; Frank Ruschitzka; A Michael Lincoff; Steven E Nissen
Rationale, design, and governance of Prospective Randomized Evaluation of Celecoxib Integrated Safety versus Ibuprofen Or Naproxen (PRECISION), a cardiovascular end point trial of nonsteroidal antiinflammatory agents in patients with arthritis.
American heart journal 2009;157(4):606-12.
2009: Johannes Holzmeister; David Hürlimann; Jan Steffel; Frank Ruschitzka
Cardiac resynchronization therapy in patients with a narrow QRS.
Current heart failure reports 2009;6(1):49-56.
2009: Andreas J Flammer; N T T Vo; bruno ledergerber; Frank Hermann; A Gämperli; A Huttner; J Evison; Iris Baumgartner; Matthias Cavassini; Daniel Hayoz; Kurt Quitzau; Martin Hersberger; Isabella Sudano; Frank Ruschitzka; Thomas F Lüscher; Georg Noll; Rainer Weber
Effect of atazanavir versus other protease inhibitor-containing antiretroviral therapy on endothelial function in HIV-infected persons: randomised controlled trial.
Heart (British Cardiac Society) 2009;95(5):385-90.
2009: Matthias Hermann; Frank Ruschitzka
The hypertension peril: lessons from CETP inhibitors.
Current hypertension reports 2009;11(1):76-80.
2009: Frank Enseleit; Frank Ruschitzka
The BEAUTIFUL study: is heart rate reduction a new therapeutic principle?
Current hypertension reports 2009;11(1):45-7.
2009: Frank Hermann; Frank Enseleit; Lukas E Spieker; Daniel Périat; Isabella Sudano; Matthias Hermann; Roberto Corti; Georg Noll; Frank Ruschitzka; Thomas F Lüscher
Cholesterylestertransfer protein inhibition and endothelial function in type II hyperlipidemia.
Thrombosis research 2009;123(3):460-5.
2008: Isabella Sudano; Andreas J Flammer; Frank Hermann; Thomas Syburra; Priska Kaiser; Astrid Hirt; Matthias Hermann; Roberto Corti; Frank Ruschitzka; Gregor Zund; Georg Noll
Auricall. A new device for a non-invasive, wireless, continuous monitoring of oxygen saturation and heart rate in patients with heart failure.
International journal of cardiology 2008;129(1):141-3.
2008: Frank Enseleit; Thomas F Lüscher; Frank Ruschitzka
Darusentan: a new perspective for treatment of resistant hypertension?
Expert opinion on investigational drugs 2008;17(8):1255-63.
2008: Frank Enseleit; Nicolas J Mueller; Firat Duru; Mario Lachat; Georg Noll; Frank Ruschitzka
Teicoplanin-induced complete AV-block in a heart transplant recipient.
Infection 2008;36(3):291-2.
2008: Andreas J Flammer; Isabella Sudano; Frank Hermann; Steffen Gay; Adrian Forster; Michel Neidhart; Peter Künzler; Frank Enseleit; Daniel Périat; Matthias Hermann; Jürg Nussberger; Thomas F Luscher; Roberto Corti; Georg Noll; Frank Ruschitzka
Angiotensin-converting enzyme inhibition improves vascular function in rheumatoid arthritis.
Circulation 2008;117(17):2262-9.
2008: Francesco Cosentino; David Hürlimann; C Delli Gatti; Rémy Chenevard; Nenad Blau; N J Alp; K M Channon; M Eto; P Lerch; Frank Enseleit; Frank Ruschitzka; M Volpe; Thomas F Lüscher; Georg Noll
Chronic treatment with tetrahydrobiopterin reverses endothelial dysfunction and oxidative stress in hypercholesterolaemia.
Heart (British Cardiac Society) 2008;94(4):487-92.
2008: Matthias Hermann; Frank Ruschitzka
Vitamin D and hypertension.
Current hypertension reports 2008;10(1):49-51.
2007: Andreas J Flammer; Frank Hermann; Isabella Sudano; Lukas E Spieker; Matthias Hermann; Karen A Cooper; Mauro Serafini; Thomas F Lüscher; Frank Ruschitzka; Georg Noll; Roberto Corti
Dark chocolate improves coronary vasomotion and reduces platelet reactivity.
Circulation 2007;116(21):2376-82.
2007: Andreas J Flammer; Frank Hermann; Peter Wiesli; Beat Schwegler; Rémy Chenevard; David Hürlimann; Isabella Sudano; Steffen Gay; Michel Neidhart; Walter Riesen; Frank Ruschitzka; Thomas F Lüscher; Georg Noll; Roger Lehmann
Effect of losartan, compared with atenolol, on endothelial function and oxidative stress in patients with type 2 diabetes and hypertension.
Journal of hypertension 2007;25(4):785-91.
2007: Isabella Sudano; Matthias Hermann; Frank Ruschitzka
Endothelin-receptor antagonists in arterial hypertension: further indications?
Current hypertension reports 2007;9(1):59-65.
2007: Frank Ruschitzka
Painful lessons: COX-2 inhibitors, NSAIDs, and hypertension.
Current hypertension reports 2007;9(1):41-4.
2007: Giovanni G Camici; Thomas Stallmach; Matthias Hermann; Rutger J Hassink; Peter Doevendans; Beat Grenacher; Alain Hirschy; Johannes Vogel; Thomas F Lüscher; Frank Ruschitzka; Max Gassmann
Constitutively overexpressed erythropoietin reduces infarct size in a mouse model of permanent coronary artery ligation.
Methods in enzymology 2007;435():147-55.
2007: Matthias Hermann; Frank Ruschitzka
Cardiovascular risk of cyclooxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs.
Annals of medicine 2007;39(1):18-27.
2006: Rémy Chenevard; M Bechir; D Hurlimann; Frank Ruschitzka; J Turina; Thomas F Luscher; Georg Noll
Persistent endothelial dysfunction in calcified aortic stenosis beyond valve replacement surgery.
Heart (British Cardiac Society) 2006;92(12):1862-3.
2006: Jan Steffel; Alexander Akhmedov; Carine Fähndrich; Frank Ruschitzka; Thomas F Lüscher; Felix C Tanner
Differential effect of celecoxib on tissue factor expression in human endothelial and vascular smooth muscle cells.
Biochemical and biophysical research communications 2006;349(2):597-603.
2006: Lukas E Spieker; Andreas J Flammer; Nadja Amacker; Isabella Sudano; Juan J Badimon; Frank Ruschitzka; Thomas F Lüscher; Georg Noll; Roberto Corti
C-reactive protein influences shear stress-dependent platelet adhesion in patients with familiar hypercholesterolemia and coronary artery disease undergoing LDL apheresis.
Thrombosis and haemostasis 2006;96(4):540-2.
2006: Matthias Hermann; Frank Ruschitzka
Novel anti-inflammatory drugs in hypertension.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2006;21(4):859-64.
2006: Frank Enseleit; Christophe A Wyss; Firat Duru; Georg Noll; Frank Ruschitzka
Images in cardiovascular medicine. The blue man: amiodarone-induced skin discoloration.
Circulation 2006;113(5):e63.
2006: Jan Steffel; Thomas F Lüscher; Frank Ruschitzka; Felix C Tanner
Cyclooxygenase-2 inhibition and coagulation.
Journal of cardiovascular pharmacology 2006;47 Suppl 1():S15-20.
2006: Henry Krum; Frank Ruschitzka
'Class effect' amongst cardiac drugs: term of convenience or pharmacological reality?
International journal of clinical practice 2006;60(1):2-5.
2006: Frank Hermann; Lukas E Spieker; Frank Ruschitzka; Isabella Sudano; Matthias Hermann; Christian Binggeli; Thomas F Lüscher; Walter Riesen; Georg Noll; Roberto Corti
Dark chocolate improves endothelial and platelet function.
Heart (British Cardiac Society) 2006;92(1):119-20.
2006: David Hürlimann; Rémy Chenevard; Frank Ruschitzka; M Flepp; Frank Enseleit; Markus Béchir; Richard Kobza; Jörg Muntwyler; bruno ledergerber; Thomas F Lüscher; Georg Noll; R Weber
Effects of statins on endothelial function and lipid profile in HIV infected persons receiving protease inhibitor-containing anti-retroviral combination therapy: a randomised double blind crossover trial.
Heart (British Cardiac Society) 2006;92(1):110-2.
2005: Frank Ruschitzka
Are selective cyclo-oxygenase 2 inhibitors safe after coronary artery bypass grafting surgery?
Nature clinical practice. Cardiovascular medicine 2005;2(10):504-5.
2005: Frank Hermann; Frank Ruschitzka; Lukas E Spieker; Isabella Sudano; Georg Noll; Roberto Corti
[The sweet secret of dark chocolate].
Therapeutische Umschau. Revue thérapeutique 2005;62(9):635-7.
2005: Isabella Sudano; Lukas E Spieker; Christian Binggeli; Frank Ruschitzka; Thomas F Lüscher; Georg Noll; Roberto Corti
Coffee blunts mental stress-induced blood pressure increase in habitual but not in nonhabitual coffee drinkers.
Hypertension 2005;46(3):521-6.
2005: Matthias Hermann; Henry Krum; Frank Ruschitzka
To the heart of the matter: coxibs, smoking, and cardiovascular risk.
Circulation 2005;112(7):941-5.
2005: Jan Steffel; Matthias Hermann; Helen Greutert; Steffen Gay; Thomas F Lüscher; Frank Ruschitzka; Felix C Tanner
Celecoxib decreases endothelial tissue factor expression through inhibition of c-Jun terminal NH2 kinase phosphorylation.
Circulation 2005;111(13):1685-9.
2005: Matthias Hermann; Frank Enseleit; Frank Ruschitzka
Anti-inflammatory strategies in hypertension: focus on COX-1 and COX-2.
Current hypertension reports 2005;7(1):52-60.
2005: Frank Ruschitzka
Clinical trials report. The APPROVe study: what we should learn from the VIOXX withdrawal.
Current hypertension reports 2005;7(1):41-3.
2005: Frank Hermann; Adrian Forster; Rémy Chenevard; Frank Enseleit; David Hürlimann; Roberto Corti; Lukas E Spieker; Diana Frey; Matthias Hermann; Walter Riesen; Michel Neidhart; Beat A Michel; Jens P Hellermann; Renate E Gay; Thomas F Lüscher; Steffen Gay; Georg Noll; Frank Ruschitzka
Simvastatin improves endothelial function in patients with rheumatoid arthritis.
Journal of the American College of Cardiology 2005;45(3):461-4.
2005: Matthias Hermann; Sidney Shaw; Eva Kiss; Giovanni G Camici; Nico Bühler; Rémy Chenevard; Thomas F Lüscher; Hermann J Gröne; Frank Ruschitzka
Selective COX-2 inhibitors and renal injury in salt-sensitive hypertension.
Hypertension 2005;45(2):193-7.
2005: Isabella Sudano; Christian Binggeli; Lukas E Spieker; Thomas Felix Lüscher; Frank Ruschitzka; Georg Noll; Roberto Corti
Cardiovascular effects of coffee: is it a risk factor?
Progress in cardiovascular nursing 2005;20(2):65-9.
2004: David Hürlimann; Frank Enseleit; Frank Ruschitzka
[Rheumatoid arthritis, inflammation, and atherosclerosis].
Herz 2004;29(8):760-8.
2004: Lorenz Dorschner; Rudolf Speich; Frank Ruschitzka; Jörg D Seebach; Augusto Gallino
Everolimus-induced drug fever after heart transplantation.
Transplantation 2004;78(2):303-4.
2004: Inder Anand; John McMurray; Jay N Cohn; Marvin A Konstam; Thomas Notter; Kurt Quitzau; Frank Ruschitzka; Thomas F Lüscher
Long-term effects of darusentan on left-ventricular remodelling and clinical outcomes in the EndothelinA Receptor Antagonist Trial in Heart Failure (EARTH): randomised, double-blind, placebo-controlled trial.
Lancet 2004;364(9431):347-54.
2004: Bilgehan Karadag; Lukas E Spieker; Juerg Schwitter; Frank Ruschitzka; Thomas F Lüscher; Georg Noll; Roberto Corti
Lyme carditis: restitutio ad integrum documented by cardiac magnetic resonance imaging.
Cardiology in review 2004;12(4):185-7.
2004: Lukas E Spieker; Frank Ruschitzka; Thomas F Lüscher; Georg Noll
HDL and inflammation in atherosclerosis.
Current drug targets. Immune, endocrine and metabolic disorders 2004;4(1):51-7.
2004: Frank Hermann; Frank Ruschitzka; Ernesto L Schiffrin
Clinical trials report. CHARM-Preserved Trial.
Current hypertension reports 2004;6(1):48-50.
2004: Frank Hermann; Frank Ruschitzka; Ernesto L Schiffrin
Clinical trials report. CHARM-Added Trial.
Current hypertension reports 2004;6(1):47.
2004: Frank Hermann; Frank Ruschitzka; Ernesto L Schiffrin
Clinical trials report. CHARM-Alternative Trial.
Current hypertension reports 2004;6(1):47.
2004: Frank Hermann; Frank Ruschitzka; Ernesto L Schiffrin
Clinical trials report. CHARM-Overall Programme.
Current hypertension reports 2004;6(1):46.
2004: Frank Hermann; Frank Ruschitzka; Ernesto L Schiffrin
Clinical trials report. The sweet secret of dark chocolate.
Current hypertension reports 2004;6(1):45-6.
2004: Lukas E Spieker; Frank Ruschitzka; Juan J Badimon; Georg Noll; Roberto Corti
Shear stress-dependent platelet function after LDL cholesterol apheresis.
Thrombosis research 2004;113(6):395-8.
2003: Matthias Hermann; Giovanni G Camici; Aisha Fratton; David Hurlimann; Felix C Tanner; Jens P Hellermann; Georg Martin Fiedler; Joachim Thiery; Michel Neidhart; Renate E Gay; Steffen Gay; Thomas F Lüscher; Frank Ruschitzka
Differential effects of selective cyclooxygenase-2 inhibitors on endothelial function in salt-induced hypertension.
Circulation 2003;108(19):2308-11.
2003: Markus Béchir; Christian Binggeli; Roberto Corti; Rémy Chenevard; Lukas E Spieker; Frank Ruschitzka; Thomas F Lüscher; Georg Noll
Dysfunctional baroreflex regulation of sympathetic nerve activity in patients with vasovagal syncope.
Circulation 2003;107(12):1620-5.
2003: Daniel Neff; Frank Ruschitzka; Martin Hersberger; Frank Enseleit; David Hürlimann; Georg Noll; Thomas Lüscher; Edgar Hänseler
Detection of a novel exon 4 low-density lipoprotein receptor gene deletion in a swiss family with severe familial hypercholesterolemia.
Clinical chemistry and laboratory medicine : CCLM / FESCC 2003;41(3):266-71.
2003: Frank Ruschitzka
Comparison of omapatrilat and enalapril in patients with chronic heart failure: the Omapatrilat Versus Enalapril Randomized Trial of Utility in Reducing Events (OVERTURE).
Current hypertension reports 2003;5(1):57-8.
2003: Thomas Quaschning; Frank Ruschitzka; Thomas Stallmach; Sidney Shaw; Henning Morawietz; Winfried Goettsch; Matthias Hermann; Torsten Slowinski; Franz Theuring; Berthold Hocher; Thomas F Lüscher; Max Gassmann
Erythropoietin-induced excessive erythrocytosis activates the tissue endothelin system in mice.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2003;17(2):259-61.
2003: Rémy Chenevard; David Hürlimann; Markus Béchir; Frank Enseleit; Lukas E Spieker; Matthias Hermann; Walter Riesen; Steffen Gay; Renate E Gay; Michel Neidhart; Beat Michel; Thomas F Lüscher; Georg Noll; Frank Ruschitzka
Selective COX-2 inhibition improves endothelial function in coronary artery disease.
Circulation 2003;107(3):405-9.
2002: Roberto Corti; Christian Binggeli; Isabella Sudano; Lukas E Spieker; Edgar Hänseler; Frank Ruschitzka; William Chaplin; Thomas F Lüscher; Georg Noll
Coffee acutely increases sympathetic nerve activity and blood pressure independently of caffeine content: role of habitual versus nonhabitual drinking.
Circulation 2002;106(23):2935-40.
2002: Thomas F Lüscher; Frank Enseleit; Richard Pacher; Veselin Mitrovic; Matthias R Schulze; Roland Willenbrock; Rainer Dietz; Valentin Rousson; David Hürlimann; Sebastian Philipp; Thomas Notter; Georg Noll; Frank Ruschitzka
Hemodynamic and neurohumoral effects of selective endothelin A (ET(A)) receptor blockade in chronic heart failure: the Heart Failure ET(A) Receptor Blockade Trial (HEAT).
Circulation 2002;106(21):2666-72.
2002: David Hürlimann; Adrian Forster; Georg Noll; Frank Enseleit; Rémy Chenevard; Oliver Distler; Markus Béchir; Lukas E Spieker; Michel Neidhart; Beat A Michel; Renate E Gay; Thomas F Lüscher; Steffen Gay; Frank Ruschitzka
Anti-tumor necrosis factor-alpha treatment improves endothelial function in patients with rheumatoid arthritis.
Circulation 2002;106(17):2184-7.
2002: Sebastian Philipp; Jan Monti; Ines Pagel; Thomas Langenickel; Thomas Notter; Frank Ruschitzka; Thomas Lüscher; Rainer Dietz; Roland Willenbrock
Treatment with darusentan over 21 days improved cGMP generation in patients with chronic heart failure.
Clinical science (London, England : 1979) 2002;103 Suppl 48():249S-253S.
2002: Torsten Slowinski; Norma Schulz; Frank Ruschitzka; Thomas Quaschning; Christian Bauer; Franz Theuring; Hans-Hellmut Neumayer; Max Gassmann; Berthold Hocher
Pattern of prepro-endothelin-1 expression revealed by reporter-gene activity in kidneys of erythropoietin-overexpressing mice.
Clinical science (London, England : 1979) 2002;103 Suppl 48():44S-47S.
2002: Lukas E Spieker; Frank Ruschitzka; Thomas F Lüscher; Georg Noll
The management of hyperuricemia and gout in patients with heart failure.
European journal of heart failure 2002;4(4):403-10.
2002: Lukas E Spieker; David Hürlimann; Frank Ruschitzka; Roberto Corti; Frank Enseleit; Sidney Shaw; Daniel Hayoz; John E Deanfield; Thomas F Lüscher; Georg Noll
Mental stress induces prolonged endothelial dysfunction via endothelin-A receptors.
Circulation 2002;105(24):2817-20.
2002: Lukas E Spieker; Isabella Sudano; David Hürlimann; Peter G Lerch; Markus G Lang; Christian Binggeli; Roberto Corti; Frank Ruschitzka; Thomas F Lüscher; Georg Noll
High-density lipoprotein restores endothelial function in hypercholesterolemic men.
Circulation 2002;105(12):1399-402.
2002: David Hürlimann; Frank Enseleit; Georg Noll; Thomas F Lüscher; Frank Ruschitzka
Endothelin antagonists and heart failure.
Current hypertension reports 2002;4(1):85-92.
2002: Thomas Quaschning; Frank Ruschitzka; Thomas F Lüscher
Vasopeptidase inhibition: effective blood pressure control for vascular protection.
Current hypertension reports 2002;4(1):78-84.
2001: Lukas E Spieker; G Noll; Frank Ruschitzka; T F Lüscher
Endothelin A receptor antagonists in congestive heart failure: blocking the beast while leaving the beauty untouched?
Heart failure reviews 2001;6(4):301-15.
2001: Thomas Quaschning; Frank Ruschitzka; B Niggli; C M Lunt; Sidney Shaw; M Christ; M Wehling; Thomas F Lüscher
Influence of aldosterone vs. endothelin receptor antagonism on renovascular function in liquorice-induced hypertension.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2001;16(11):2146-51.
2001: Thomas Quaschning; Livius V d'Uscio; Sidney Shaw; H J Gröne; Frank Ruschitzka; Thomas F Lüscher
Vasopeptidase inhibition restores renovascular endothelial dysfunction in salt-induced hypertension.
Journal of the American Society of Nephrology : JASN 2001;12(11):2280-7.
2001: Roberto Corti; J C Burnett; J L Rouleau; Frank Ruschitzka; Thomas F Lüscher
Vasopeptidase inhibitors: a new therapeutic concept in cardiovascular disease?
Circulation 2001;104(15):1856-62.
2001: Frank Ruschitzka; Thomas Quaschning; Georg Noll; A deGottardi; M F Rossier; Frank Enseleit; David Hürlimann; Thomas F Lüscher; S G Shaw
Endothelin 1 type a receptor antagonism prevents vascular dysfunction and hypertension induced by 11beta-hydroxysteroid dehydrogenase inhibition: role of nitric oxide.
Circulation 2001;103(25):3129-35.
2001: Thomas Quaschning; Livius V d'Uscio; Sidney Shaw; H Viswambharan; Frank Ruschitzka; Thomas F Lüscher
Chronic vasopeptidase inhibition restores endothelin-converting enzyme activity and normalizes endothelin levels in salt-induced hypertension.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2001;16(6):1176-82.
2001: Lukas E Spieker; G Noll; Frank Ruschitzka; T F Lüscher
Endothelin receptor antagonists in congestive heart failure: a new therapeutic principle for the future?
Journal of the American College of Cardiology 2001;37(6):1493-505.
2001: Thomas Quaschning; Frank Ruschitzka; Sidney Shaw; Thomas F Lüscher
Aldosterone receptor antagonism normalizes vascular function in liquorice-induced hypertension.
Hypertension 2001;37(2 Pt 2):801-5.
2000: Lukas E Spieker; G Noll; Frank Ruschitzka; W Maier; T F Lüscher
Working under pressure: the vascular endothelium in arterial hypertension.
Journal of human hypertension 2000;14(10-11):617-30.
2000: Frank Ruschitzka; U Moehrlen; Thomas Quaschning; Mario Lachat; G Noll; Sidney Shaw; Zhihong Yang; D Teupser; T Subkowski; Marko I Turina; Thomas F Lüscher
Tissue endothelin-converting enzyme activity correlates with cardiovascular risk factors in coronary artery disease.
Circulation 2000;102(10):1086-92.
1999: Frank Ruschitzka; Georg Noll; Thomas F Lüscher
Angiotensin converting enzyme inhibitors and vascular protection in hypertension.
Journal of cardiovascular pharmacology 1999;34 Suppl 1():S3-12.
1999: Frank Ruschitzka; S Shaw; D Gygi; Georg Noll; Matthias Barton; Thomas F Lüscher
Endothelial dysfunction in acute renal failure: role of circulating and tissue endothelin-1.
Journal of the American Society of Nephrology : JASN 1999;10(5):953-62.
1998: Frank Ruschitzka; Georg Noll; Thomas F Lüscher
Combination of ACE inhibitors and calcium antagonists: a logical approach.
Journal of cardiovascular pharmacology 1998;31 Suppl 2():S5-16.
1997: Zhihong Yang; Frank Ruschitzka; ton rabelink; Georg Noll; F Julmy; Hana Joch; V Gafner; I Aleksic; U Althaus; Thomas F Lüscher
Different effects of thrombin receptor activation on endothelium and smooth muscle cells of human coronary bypass vessels. Implications for venous bypass graft failure.
Circulation 1997;95(7):1870-6.
1997: Frank Ruschitzka; G Noll; T F Lüscher
The endothelium in coronary artery disease.
Cardiology 1997;88 Suppl 3():3-19.
1996: Frank Ruschitzka; T F Lüscher
Endothelin: culprit or bystander in Addison's disease?
European journal of endocrinology / European Federation of Endocrine Societies 1996;135(6):645-8.